ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/03/2024
Back to search
Official data from USPTO
COVANT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
COVANT
ST13
US500000097776624Class
1, 5, 42
Filing
97776624
Registration
7236449
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
04/03/2024
Trademark type
Word
Nice classes
1, 5, 42
Filing date
02/01/2023
Registration date
12/05/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/05/2023
Last transaction
12/05/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
03
Owner location
BOSTON, MA
Examiner
SANGID, HANA
Law office
O10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
COVANT THERAPEUTICS OPERATING, INC.
Roivant Sciences GmbH
Representatives
Joyce M. Ferraro FROSS ZELNICK LEHRMAN & ZISSU, P.C.
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biologicalpharmaceutical preparations for scientificresearchlaboratory usefor the manufacture of pharmaceuticals; biochemicals for in vivoex vivoon vivo or in vitro scientific research and medical researchfor use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders
Class 5
Pharmaceutical preparations for human use for the treatment of viruses and respiratory diseasesdisorders and conditions; biologic preparations for medical and therapeutic purposes for the treatment of viruses and respiratory diseasesdisorders and conditions; drug carriers for medical usedrug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
Class 42
Pharmaceutical drug discovery services; discovery and development of therapeutic drugs that form a bond with an intended target; discovering and developing novel therapeutic pharmaceuticals using a chemoproteomics hit finding engine; pharmaceutical and biotechnology research and development services; drug use discovery services; design and development of pharmaceutical preparations and medicines; research and development in the field of drug discovery; pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; designengineeringresearchdevelopment services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research information in the fields of pharmaceuticals and biologics
Publications
History of USPTO decisions and trademark events.
18 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/05/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
12/05/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/19/2023
PUBO
PUBLISHED FOR OPPOSITION
09/19/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/30/2023
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
08/17/2023
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
08/11/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/08/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/02/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/02/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/02/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/27/2023
GNRT
NON-FINAL ACTION E-MAILED
06/27/2023
CNRT
NON-FINAL ACTION WRITTEN
06/27/2023
DOCK
ASSIGNED TO EXAMINER
05/31/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/21/2023
NWAP
NEW APPLICATION ENTERED
02/07/2023
Continuous trademark protection
Get notified about every new filing that threatens COVANT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.